HEXIM1 and melanoma: Tan and colleagues utilized Oncomine expression data to evaluate the role of candidate transcription elongation regulators in melanoma and found that HEXIM1 P-TEFb complex subunit 1 (HEXIM1) expression was significantly reduced in melanomas compared to nevi [49,54].